TP53 and ovarian serous carcinoma: We consider that these genetic changes are somatic because they were not present in cfDNA after tumor resection and had low VAF—generally characteristic for the somatic mutations.32,33 The most mutated variants were observed in the TP53 gene in the high-grade serous ovarian carcinoma (HGSOC) patients.